Immunomodulation refers to the alteration of immune responses, either suppression or enhancement, to achieve a therapeutic effect. Stem cells, particularly mesenchymal stem cells (MSCs), have garnered attention for their capacity to modulate immune responses in CNS disorders.
Here are some key points:
- Suppressing T-cell activity: MSCs can inhibit the actions of effector T-cells, immune cells that can cause damage during autoimmune responses. By reducing T-cell activity, these stem cells can help lessen inflammation that contributes to disease progression.
- Inducing regulatory cells: They promote the development of regulatory T-cells (Tregs), which are crucial for suppressing autoimmune reactions and maintaining immune balance.
- Reducing inflammation: Stem cells release anti-inflammatory factors that can minimize tissue damage and support CNS repair mechanisms.
Stem cell-driven immunomodulation holds potential in treating autoimmune CNS disorders like multiple sclerosis, offering a novel strategy to balance the immune system's response.